Product Images Oxcarbazepine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Oxcarbazepine NDC 68084-867 by American Health Packaging, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a medication with the National Drug Code (NDC) 68084-845-01. The drug is Oxcarbazepine, and it is in the form of tablets. Each bottle contains 100 tablets packaged in 10x10. The recommended dosage for the medication is not provided but can be accessed from the package insert that comes with the bottle. It is advisable to store the medication within a temperature range of 68 to 77 degrees Fahrenheit. The drug's manufacturers caution to keep the medication out of children's reach, and users should not use a torn or open bottle. The medication is manufactured and distributed by American Health Packaging in Ohio.*
This is a medication package of Oxcarbazepine Tablets, USP containing 100 Tablets (10 x 10). Each tablet contains Grcarbazepine 300mg and is film-coated. The usual dosage information is available in the package insert. It is advised to store it between 20°C to 25°C (68°F to 77°F). This drug should be kept away from the reach of children. The package is manufactured by Breckanridge Pramaceutcal Inc. and packaged and distributed by American Health Packaging. The NDC code for this medication is 68084-853-01.*
Oxcarbazepine is a prescription drug available in film-coated tablet form. Each tablet contains 800mg of Oxcarbazepine and is coated with yellow food color No. 5 (artazine). The recommended dosage is mentioned in the prescribing package. The tablets must be stored at a temperature ranging from 20°C to 25°C (68°F to 77°F) and should be kept away from children. This drug is distributed by American Health Packaging in Columbus, Ohio.*
This is a statistical analysis report of a rank test (Seizur Rale) with a P-value of 0.046. The data contains results from a treatment group (Oxcarbazepine) and a control group (Placebo) across 140 days with the dose of the 1st Seizure as a parameter.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.